Clinical Trial Update: 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

53-week Phase 2 trial evaluating the safety and efficacy of intra-articular TPX-100 injections for tibio-femoral knee osteoarthritis; study status is active_not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• TPX-100

Snippet

Sponsor: OrthoTrophix, Inc | Conditions: Osteoarthritis (OA) of the Knee | Phase 2 | Status: ACTIVE_NOT_RECRUITING